2 Interesting Developments on 2 Major Marijuana Producers This Month

Find out the two interesting developments from Aphria Inc. (TSX:APH) and Aurora Cannabis Inc. (TSXV:ACB) in the marijuana space.

| More on:

The local marijuana industry is still in a fast-paced development mode as the incumbent competitors vie for market share, both on the consumer market and on the investor market front. There have been two interesting developments with Aurora Cannabis Inc. (TSXV:ACB) and Aphria Inc. (TSX:APH).

Aurora Cannabis Inc.

The local marijuana industry’s most aggressive kid — Aurora Cannabis — has finally come of age, way faster than its big brothers.

Aurora has just announced that it’s finally graduating from the junior TSX Venture exchange (TSXV) to the senior TSX. The company has received conditional approval from the Toronto Stock Exchange to list its shares on the main TSX.

With this graduation, Aurora seeks to attract the more senior and savvy investors, especially institutional investors and money managers whose mandates and internal policies only allow them to invest in companies listed on the senior TSX.

The date for this graduation has not been given as of yet though, so the market may be given a clearer message on the issue in a short while. The CEO, however, says the final approval is “imminent.”

Judging from history, Aphria announced its conditional graduation approval from the TSXV on February 6, 2017, and finally graduated on March 22, while Canopy Growth Corp. announced the granting of its conditional approval on June 6, 2016, and finally graduated on July 26 the same year.

Therefore, by simple inference, Aurora shares could be trading on the major TSX by late next month.

Institutional investors are believed to bring better price discovery on a stock and somehow bring some price stability on a ticker, but when they decide to exit, the stock may take a deeper plunge.

Aphria Inc.

Aphria seems to be increasing its pace on the United States-focused international expansion program announced April 4, 2017.

The company may have applied for a cannabis-growing licence in the newly legalized Ohio State market.

As one popular cannabis analyst, Alan Brochstein, CFA, has verified, Aphria has gone into a partnership with the well-known Schottenstein family of Ohio, and the two are reported to have applied for a Level I growing licence.

The Ohio State has 12 licences for grabs in two categories: Level I and Level II.

The data released by The Ohio Department of Commerce about applicants has Schottenstein Aphria LLC as one of the 109 Level I licence applicants.

Level I applicants will be allowed to grow from an initially capped capacity of 25,000-square-feet facility, while the smaller Level II applicants will have their production confined to a 3,000-square-feet growing space.

If the Schottenstein-Aphria partnership manages to grab one of the 12 licences in the applied category, then Ohio will become the third U.S state in which the marijuana producer will have a presence.

Curently, Aphria has operations in Arizona through its 18.5% stake in Copperstate Farms LLC, and in Florida through its strategic investment in Liberty Health Sciences Inc., set to trade a “Aphria USA.”

Foolish bottom line

The above developments could be good news for investors in the two concerned marijuana producers, especially for Aphria shareholders if the company manages to grab a licence. Aurora investors may continue to see more institutional investors among them.

Institutional investors are big elephants; they could bring joy to shareholders as the stock price will track intrinsic value more closely, but should there be a wrong move from Aurora management, the resultant stock price plunge could be magnified as the elephants move out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any stocks mentioned.

More on Investing

money goes up and down in balance
Dividend Stocks

1 Practically Perfect Canadian Stock Down 7% to Buy and Hold Forever

Some growth stocks have huge recovery strategy potential, and this top Canadian stock is one of them.

Read more »

calculate and analyze stock
Dividend Stocks

Key Canadian Dividend Stocks to Compound Wealth Over 2025

These three Canadian stocks are excellent buys, given their high yields and consistent dividend payments.

Read more »

The sun sets behind a power source
Dividend Stocks

3 Top Utility Sector Stocks for Canadian Investors in 2025

Here are three of the best Canadian utility stocks you can buy in 2025 and hold for years to come.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

The 1 Single Stock That I’d Hold Forever in a TFSA

There are plenty of great stocks to buy, but this gem is the one single stock that that I’d hold…

Read more »

protect, safe, trust
Dividend Stocks

Trump-Proof Your Portfolio: 3 Protected Canadian Stocks

EQB Inc (TSX:EQB) is a small bank with no U.S. presence. It seems pretty Trump-proof.

Read more »

open vault at bank
Bank Stocks

Better Bank Stock: Royal Bank vs TD Bank?

Royal Bank and TD Bank have delivered very different results for investors in the past few years.

Read more »

edit Safe pig, protect money
Investing

Defensive TSX Picks: 3 Stalwarts for Market Uncertainty

Given their solid underlying businesses and stable cash flows, these three Canadian stocks are ideal buys in an uncertain outlook.

Read more »

Investor wonders if it's safe to buy stocks now
Dividend Stocks

Is Brookfield Renewable Stock a Buy for its 7% Yield?

Down over 50% from all-time highs, Brookfield Renewable is a top TSX dividend stock to own in January 2025. Let's…

Read more »